Delaware Court Rejects Bid to Dismiss Shareholder Lawsuit Against Coinbase
03.02.2026 - 16:24:05 | boerse-global.de
A Delaware court has dealt a procedural setback to Coinbase in an ongoing legal battle. The Court of Chancery has denied a motion to terminate a shareholder lawsuit, allowing the case alleging insider trading around the company's 2021 direct listing to proceed.
On January 30, the Delaware Court of Chancery rejected a request from a Special Litigation Committee to dismiss the derivative suit. This legal action, filed on behalf of the company against its own directors and officers, centers on claims that insiders profited from non-public information during Coinbase's market debut in April 2021.
The court's decision hinged not on the merits of the allegations but on concerns regarding the committee's impartiality. Specifically, the independence of one committee member, Gokul Rajaram, was called into question due to his extensive ties to Marc Andreessen and the venture capital firm Andreessen Horowitz.
Questionable Independence Halts Dismissal
In its ruling, the court detailed multiple financial and professional connections between Rajaram and Andreessen, casting doubt on the committee's ability to conduct an objective review. Cited links included:
- A $200,000 investment by Andreessen in Rajaram's startup in 2007.
- More than 50 co-investments made by Rajaram's investment firm alongside Andreessen Horowitz since 2019.
- Further investments totaling $850,000 from Andreessen into Rajaram's firm between 2020 and 2023.
- The exchange of hundreds of emails between Rajaram and Andreessen Horowitz during the committee's investigation.
Andreessen Horowitz itself was a major seller during the direct listing, cashing out Coinbase shares worth over $118 million in what was reported as the venture firm's largest exit at the time.
The Core of the 2021 Direct Listing Controversy
Coinbase's unusual path to going public involved a direct listing, a method that lacks the standard lock-up period restricting insider sales immediately after a debut. The lawsuit contends that directors and officers sold approximately $2.9 billion worth of shares shortly after trading began.
Should investors sell immediately? Or is it worth buying Coinbase?
Plaintiffs allege these insiders were aware of impending negative earnings news, thereby avoiding losses exceeding $1 billion when the stock price subsequently declined.
A Special Litigation Committee had previously investigated for over ten months, reviewing 60,000 documents and interviewing 21 witnesses. Its conclusion, detailed in a 332-page report, was that the claims lacked merit. The recent court ruling, however, has invalidated the committee's recommendation to dismiss the suit, citing the perceived lack of independence rather than disputing the report's factual findings.
Implications for Coinbase and Investors
The court was careful to note that its ruling does not determine the ultimate truth of the insider trading allegations. It emphasized that defendants could still prevail in later stages of litigation and that the committee's report might still support their defense on the substantive issues.
Nevertheless, the decision ensures continued legal uncertainty for the cryptocurrency exchange. This overhang coincides with a challenging period for the stock, which has declined by approximately 37% over the past 30 trading days.
Market attention will now also turn to operational performance. Coinbase is scheduled to report its fourth-quarter 2025 results on February 12. These figures are expected to reveal the resilience of the company's trading volumes and revenues in a persistently volatile crypto market, indicating whether it can generate operational momentum alongside its legal challenges.
Ad
Coinbase Stock: Buy or Sell?! New Coinbase Analysis from February 3 delivers the answer:
The latest Coinbase figures speak for themselves: Urgent action needed for Coinbase investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 3.
Coinbase: Buy or sell? Read more here...
So schätzen unsere Börsenprofis Delaware Aktien ein!
Für. Immer. Kostenlos.

